BMX — BioMaxima SA Balance Sheet
0.000.00%
Last trade - 00:00
- PLN64.36m
- PLN72.01m
- PLN145.51m
- 84
- 36
- 27
- 45
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | PAS | PAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.03 | 0.518 | 4.4 | 3.01 | 12.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.63 | 5.74 | 8.55 | 16.5 | 10.5 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 18 | 18.1 | 25.4 | 33.5 | 36.2 |
Net Property, Plant And Equipment | 24.3 | 23.3 | 21.7 | 27.9 | 37.8 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 44 | 43.3 | 47.7 | 61.9 | 74.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19.5 | 20.1 | 13.1 | 17.3 | 11 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 27.2 | 26.9 | 27.8 | 32.7 | 22 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 16.8 | 16.4 | 19.9 | 29.2 | 52.5 |
Total Liabilities & Shareholders' Equity | 44 | 43.3 | 47.7 | 61.9 | 74.4 |
Total Common Shares Outstanding |